Rituxan: Don't count it out as multiple sclerosis treatment
Rituxan: Don't count it out as multiple sclerosis treatment
Numerous presentations at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting made it plain that the anti-CD20 biologic drug ocrelizumab may not have the field to itself, if and when it is approved for marketing... Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1925 Views
-
Last post by frodo
-
- 0 Replies
- 1772 Views
-
Last post by frodo
-
- 0 Replies
- 1740 Views
-
Last post by frodo
-
- 0 Replies
- 1911 Views
-
Last post by frodo
-
- 0 Replies
- 1399 Views
-
Last post by frodo
-
- 0 Replies
- 2061 Views
-
Last post by NHE
-
- 0 Replies
- 2444 Views
-
Last post by frodo
-
- 0 Replies
- 3800 Views
-
Last post by frodo
-
- 3 Replies
- 472 Views
-
Last post by Leonard